NCT01349504

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 106 (actual)
• Sponsor: Beth Israel Deaconess Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Hypothesis: Mesalamine is commonly used to induce and maintain remission in patients with Inflammatory Bowel Disease (IBD). Behavioral and psycho-social barriers to mesalamine adherence exist in patients with IBD. These factors can be identified using qualitative testing in order to develop a validated instrument to measure the "adherence profile" of an individual patient, and design appropriate behavioral interventions to reduce non-adherence. Objectives: To test a novel interview instrument that determines the medication adherence profile of patients with IBD prescribed mesalamine by correlating with objective measures of adherence

Detailed description

Specific Aims: 1. To test a novel interview instrument to classify patients into "adherence profiles" 2. To validate this instrument with quantitative scores of mesalamine adherence and objective testing. Study Design Rationale: Qualitative research design and prospective validation

Conditions

• Ulcerative Colitis
• Crohn's Disease

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2011-05-06
• Last updated: 2013-08-19

Locations

1 site across 1 country: United States